Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin

被引:7
作者
Pfaller, MA [1 ]
Jones, RN
Walter, DH
机构
[1] Univ Iowa, Coll Med, Div Med Microbiol, CAST Labs, Iowa City, IA 52242 USA
[2] JONES Grp, JMI Labs, N Liberty, IA 52242 USA
关键词
D O I
10.1016/S0732-8893(01)00239-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Quality control guidelines for standardized antimicrobial susceptibility test methods are critical for the continuing accuracy of these clinical tests. In this report, quality control limits were proposed for the veterinary antimicrobial agent tiamulin with minimum inhibitory concentration (MIC) ranges of three or four log, dilution steps in two different medium formulations. Disk diffusion zone diameter ranges were proposed for tiamulin tested against Actinobacillus pleuropneumoniae ATCC 27090 (12-18 mm) and Staphylococcus aureus ATCC 25923 (25-32 mm). The data from eight participating laboratories produced 100% of results within proposed MIC limits (8-32 mug/mL), and 95.8-97.0% of zones were found within suggested zone diameter QC guidelines. These proposed QC ranges should be validated by in-use results from veterinary clinical laboratories. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 11 条
[1]  
[Anonymous], 2000, M2A7 NCCLS
[2]   STATISTICAL CRITERIA FOR SELECTING QUALITY-CONTROL LIMITS FOR BROTH MICRODILUTION SUSCEPTIBILITY TESTS WITH 39 DIFFERENT ANTIMICROBIAL AGENTS [J].
BARRY, AL ;
FUCHS, PC ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (05) :413-420
[3]   ANTIMICROBIAL ACTIVITIES OF 81.723 HFU, A NEW PLEUROMUTILIN DERIVATIVE [J].
DREWS, J ;
GEORGOPOULOS, A ;
LABER, G ;
SCHUTZE, E ;
UNGER, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 7 (05) :507-516
[4]   QUALITY-CONTROL LIMITS FOR AMPICILLIN, CARBENICILLIN, MEZLOCILLIN, AND PIPERACILLIN DISK DIFFUSION SUSCEPTIBILITY TESTS - A COLLABORATIVE STUDY [J].
GAVAN, TL ;
JONES, RN ;
BARRY, AL ;
FUCHS, PC ;
GERLACH, EH ;
MATSEN, JM ;
RELLER, LB ;
THORNSBERRY, C ;
THRUPP, LD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 14 (01) :67-72
[5]  
HOGENAUER G, 1979, MECHANISM ACTION A 1, V5, P344
[6]   Proposed MIC quality control guidelines for national committee for clinical laboratory standards susceptibility tests using seven veterinary antimicrobial agents: Ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin [J].
Marshall, SA ;
Jones, RN ;
Wanger, A ;
Washington, JA ;
Doern, GV ;
Leber, AL ;
Haugen, TH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (08) :2027-2029
[7]  
*NAT COMM CLIN LAB, 1999, M37A NCCLS
[8]  
*NAT COMM CLIN LAB, 1999, M31A NCCLS
[9]  
*NAT COMM CLIN LAB, 2001, M23A2 NCCLS
[10]  
National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS